Symposium:
41. The Influence of the Microbiome on Infectious Disease Pathogenesis
Thursday, October 27, 2016: 10:30 AM-12:00 PM
Room: 291-292

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • outline the recent advances in understanding the role of the indigenous microbiota in the pathogenesis of gastrointestinal infections
  • discuss the role microbial communities may play in the pathogenesis of lung disease in patients with cystic fibrosis
  • evaluate developing strategies for the management of infectious diseases that target the manipulation of the microbiome

Target Audience: Academicians, Clinicians, Fellows, Investigators, Lab personnel, Members-in-training, Microbiologists, Researchers, Scientists

Tracks: Pediatric ID, Investigative ID, Adult ID

Moderators:  Vincent B. Young, MD, PhD, FIDSA, University of Michigan and Colleen Kraft, MD, MSc, Emory University School of Medicine

Presentations:
10:30 AM
111
The Microbiome in Gastrointestinal Infections
James Versalovic, MD, PhD

10:55 AM
Q&A
11:00 AM
112
The Microbiome in Infectious Diseases of the Lung
Alison Morris, MD, MS

11:25 AM
Q&A
11:30 AM
113
The Microbiome as a Novel Therapeutic Target
Nasia Safdar, MD, PhD, FSHEA
11:55 AM
Q&A

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-223-L04-P

Disclosures:

V. B. Young, None

C. Kraft, None

See more of: Symposium
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.